
SCIENTURE HOLDINGS INC
SCNXNASDAQTrading Snapshot
- Day Range
- $0.39 β $0.40
- 52-Week Range
- $0.24 β $2.60
- Volume
- $3.56B
- Avg Volume
- $3.87B
- Shares Outstanding
- 40.6M
- Next Earnings
- Oct 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $431,609
- Last Q Revenue
- $56,325
- P/E Ratio
- -0.2
- P/S Ratio
- 33.8x
- EPS (TTM)
- $-0.10
- Dividend Yield
- 0.00%
Why Investors Own SCNX
- βHigh-growth profile β revenue up +45.1% YoY with expanding US Equity exposure.
- βHealthy economics β 44% gross margin and 26% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About SCIENTURE HOLDINGS INC
As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
SCIENTURE HOLDINGS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift SCNX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SCIENTURE HOLDINGS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.